Theta-Burst-Stimulation in Early Rehabilitation of Stroke

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

Also called NCT02910024

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02910024
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02910024. Randomized; quadruple masking; primary purpose treatment. Start 2016-04 (actual); primary completion 2022-09-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Theta-Burst-Stimulation in Early Rehabilitation of Stroke
Acronym
TheSiReS
Condition
Stroke
Intervention (Device)
Magstim Super Rapid2 System, intermittent theta-burst-stimulation (iTBS) protocol
Intervention (Device)
Magstim Super Rapid2 System, sham-stimulation (in iTBS)
Lead sponsor
University of Cologne (class: other)

Record details

Record id
cardio:ct-nct02910024
Content hash
1d3aae8fdb443a8194639e5ecc0496faa9bc4c867c52856051f576da416d43ad